Scientists may have figured out a brand new way to treat lung cancer by using a protein that inhibits tumor growth.
This previously unknown molecule pathway could help researchers develop personalized lung cancer treatments, a new study in the journal Proceedings of the National Academy of Sciences (PNAS) reveals.
The researchers found that a protein called RBM10—previously known to be a tumor suppressor—can inhibit the growth of lung cancer by stopping the function of another protein called c-Myc drives cancer cell growth when it is overexpressed in the body.
Comments are closed.